Top Biotech Gainer: United Therapeutics

Silver Spring, Maryland-based United Therapeutics Corporation (NASDAQ: UTHR) was the top gainer on Monday March 16, 2015, according to data from Google Finance biotechnology index. The fast growing company gained over $13 or 8.14% in a one-day trading session.

The stock price was already trading well over $170 for several days and has more than doubled from its 52-week low of $84.63.

United Therapeutics topped Fluidigm Corporation, Amgen, Inc., Regeneron Pharmaceuticals, and Idera Pharmaceuticals Inc. The market value also grew nearly $1 billion to $8.24 billion.

Metro Business Media recently reported that United Therapeutics is drastically undervalued considering its revenue, continuous annual profitability and number of drugs on the market.

The stock is also getting a boost from a recent FDA approval for a cancer treatment drug called Unituxin. Not only will Unituxin be United Therapeutics fifth drug on the market, it signals a shift towards diversification of its products which have focused on treating pulmonary arterial hypertension.

Like Metro Business Media on Facebook here!

Top movers


 

Gainers (% price change)

Last Trade

Change

United Therapeutics Corp.

UTHR

176.59

+13.29 (8.14%)

Fluidigm Corporation

FLDM

43.95

+3.06 (7.48%)

Amgen, Inc.

AMGN

162.94

+8.68 (5.63%)

Regeneron Pharmaceuticals

REGN

452.18

+22.80 (5.31%)

Idera Pharmaceuticals Inc

IDRA

4.36

+0.20 (4.94%)


Stocks, Trading and Investing